Insider Transactions in Q2 2021 at Impel Pharmaceuticals Inc (IMPL)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 27
2021
|
John Hoekman Chief Scientific Officer |
SELL
Other acquisition or disposition
|
Direct |
275
-0.25%
|
-
|
|
Apr 27
2021
|
John Hoekman Chief Scientific Officer |
BUY
Conversion of derivative security
|
Direct |
4,523
+4.0%
|
-
|
|
Apr 27
2021
|
H Stewart Parker Director |
BUY
Conversion of derivative security
|
Direct |
20,151
+30.63%
|
$261,963
$13.5 P/Share
|
|
Apr 27
2021
|
H Stewart Parker Director |
SELL
Other acquisition or disposition
|
Direct |
2,124
-6.35%
|
-
|
|
Apr 27
2021
|
Ven Bio Global Strategic Fund Ii L.P. |
BUY
Open market or private purchase
|
Direct |
450,000
+14.02%
|
$6,750,000
$15.0 P/Share
|
|
Apr 27
2021
|
Ven Bio Global Strategic Fund Ii L.P. |
BUY
Conversion of derivative security
|
Direct |
2,309,791
+50.0%
|
-
|
|
Apr 27
2021
|
Norwest Venture Partners Xiv, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
825,000
+21.14%
|
$12,375,000
$15.0 P/Share
|
|
Apr 27
2021
|
Norwest Venture Partners Xiv, LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,252,198
+49.44%
|
$13,513,188
$6.75 P/Share
|
|
Apr 27
2021
|
5 Am Ventures V, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
575,000
+50.0%
|
$8,625,000
$15.0 P/Share
|
|
Apr 27
2021
|
5 Am Ventures V, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,309,791
+23.62%
|
$30,027,283
$13.5 P/Share
|
|
Apr 27
2021
|
Vivo Capital Viii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
575,000
+16.59%
|
$8,625,000
$15.0 P/Share
|
|
Apr 27
2021
|
Vivo Capital Viii, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,309,789
+23.62%
|
$30,027,257
$13.5 P/Share
|
|
Apr 27
2021
|
Kkr Iris Investors LLC |
BUY
Open market or private purchase
|
Indirect |
1,100,000
+22.44%
|
$16,500,000
$15.0 P/Share
|
|
Apr 27
2021
|
Kkr Iris Investors LLC |
BUY
Other acquisition or disposition
|
Indirect |
118,712
+4.21%
|
$1,543,256
$13.5 P/Share
|
|
Apr 27
2021
|
Kkr Iris Investors LLC |
BUY
Conversion of derivative security
|
Indirect |
2,583,926
+50.0%
|
-
|